Amid tariff turmoil, Novartis commits to spending $23B on US manufacturing
This story is reported by BioPharma Dive. Read what other outlets are saying below, then open the original report for full details.
This story is reported by BioPharma Dive. Read what other outlets are saying below, then open the original report for full details.